▶ 調査レポート

呼吸監視装置の世界市場:製品別、エンドユーザ別

• 英文タイトル:Respiratory Monitoring Devices Market (Product: Pulse Oximeters, Capnographs, Spirometers, Polysomnographs [PSG], Peak Flow Meters, Gas Analyzers, and Others; and End User: Home Care, Hospitals, Ambulatory Surgical Centers, and Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Transparency Market Researchが調査・発行した産業分析レポートです。呼吸監視装置の世界市場:製品別、エンドユーザ別 / Respiratory Monitoring Devices Market (Product: Pulse Oximeters, Capnographs, Spirometers, Polysomnographs [PSG], Peak Flow Meters, Gas Analyzers, and Others; and End User: Home Care, Hospitals, Ambulatory Surgical Centers, and Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / TPM-2JN013資料のイメージです。• レポートコード:TPM-2JN013
• 出版社/出版日:Transparency Market Research / 2019年12月30日
• レポート形態:英文、PDF、194ページ
• 納品方法:Eメール
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥846,070 (USD5,795)▷ お問い合わせ
  Multi User¥1,284,070 (USD8,795)▷ お問い合わせ
  Corporate License¥1,722,070 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは呼吸監視装置の世界市場について調査・分析し、序論、仮定・研究方法、エグゼクティブサマリー、市場状況、市場動向、製品別分析、エンドユーザ別分析、地域別(北米、欧州、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などを含め、次の構成でお届けいたします。
・序論
・仮定・研究方法
・エグゼクティブサマリー
・市場状況
・市場動向
・呼吸監視装置の世界市場:製品別
・呼吸監視装置の世界市場:エンドユーザ別
・呼吸監視装置の世界市場:地域別(北米、欧州、アジア太平洋、中南米、中東・アフリカ)
・呼吸監視装置の北米市場分析・予測
・呼吸監視装置の欧州市場分析・予測
・呼吸監視装置のアジア太平洋市場分析・予測
・呼吸監視装置の中南米市場分析・予測
・呼吸監視装置の中東・アフリカ市場分析・予測
・競争状況

High prevalence of asthma and chronic obstructive pulmonary diseases (COPDs) are some of the major factors driving the demand for respiratory monitoring devices. Hence, manufacturers in the respiratory monitoring devices market are innovating in wearable strain sensors for effective management of chronic respiratory diseases (CRDs). They are increasing efforts to introduce wearable sensors capable of providing measurements on respiration rate (RR) as well as volume with high fidelity. In order to offer more convenience to patients, manufacturers are increasing their production capabilities of disposable wearable sensors.

Companies in the respiratory monitoring devices market landscape are increasing R&D activities to develop wearable sensors that are capable of detecting respiration under various ambulatory conditions. These sensors are built on the technology of medical grade continuous spirometers. As such, spirometers record third-highest revenue in the respiratory monitoring devices market. The spirometers product segment is expected to reach value of ~US$ 1.1 Bn by the end of 2027. Hence, manufacturers are innovating in the spirometry technology for the development of innovative wearable sensors.

Polysomnography (PSG) is considered as the gold standard to receive data on respiration and sleep patterns. Companies in the respiratory monitoring devices market are increasing their efforts to develop PSG sensors that provide a wealth of information to healthcare providers. Though methods of automatic analysis are available in the healthcare industry, skilled technicians typically opt for PSG. Signal analysis and machine learning are key factors boosting the adoption of PSG in the healthcare industry. Manufacturers are increasing their research efforts in the two domains to help healthcare providers capture complex information and patterns of patients.

Moreover, new parameters for diagnosis and symptom severity are fueling the adoption of signal analysis and machine learning to enhance the outcomes via PSG. Companies in the respiratory monitoring devices market are introducing the technology of automatic detection in PSG to assess sleep-related breathing events of patients. They are making available conventional PSG sensors and new devices to identify pathological phenomena of sleep-related breathing events. Manufacturers are taking the help of well-characterized datasets to validate new algorithms related to respiratory diseases.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Respiratory Monitoring Devices Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Respiratory Monitoring Devices Market Analysis and Forecast, 2017–2027

5. Market Outlook

5.1. Technological Advancements

5.2. Prevalence of Asthma & COPD by Region/ Country

5.3. Annual Cost of COPD and Asthma

5.4. Key Industry Events (Mergers, Acquisitions, Collaborations, Launch & Approvals, etc)

5.5. Reimbursement Scenario

5.6. Overview of respiratory disease monitoring in homecare settings

6. Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Product

6.1. Introduction & Definition

6.2. Global Respiratory Monitoring Devices Market Value Forecast, by Product, 2017–2027

6.2.1. Pulse Oximeters

6.2.2. Capnographs

6.2.3. Spirometers

6.2.4. Polysomnographs (PSG)

6.2.5. Peak Flow Meters

6.2.6. Gas Analyzers

6.2.7. Others

6.3. Global Respiratory Monitoring Devices Market Attractiveness, by Product

7. Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by End User

7.1. Introduction

7.2. Global Respiratory Monitoring Devices Market Value Forecast, by End User, 2017–2027

7.2.1. Home care

7.2.2. Hospitals

7.2.3. Ambulatory Surgical Centers

7.2.4. Specialty Clinics

7.3. Global Respiratory Monitoring Devices Market Attractiveness, by End User

8. Global Respiratory Monitoring Devices Market Value (US$ Mn) Forecast, by Region

8.1. Introduction

8.2. Global Respiratory Monitoring Devices Market Value Forecast, by Region, 2017–2027

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Global Respiratory Monitoring Devices Market Attractiveness, by Region

9. North America Respiratory Monitoring Devices Market Analysis and Forecast

9.1. Introduction

9.2. North America Respiratory Monitoring Devices Market Value Forecast, by Product, 2017–2027

9.2.1. Pulse Oximeters

9.2.2. Capnographs

9.2.3. Spirometers

9.2.4. Polysomnographs (PSG)

9.2.5. Peak Flow Meters

9.2.6. Gas Analyzers

9.2.7. Others

9.3. North America Respiratory Monitoring Devices Market Value Forecast, by End User, 2017–2027

9.3.1. Home care

9.3.2. Hospitals

9.3.3. Ambulatory Surgical Centers

9.3.4. Specialty Clinics

9.4. North America Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017–2027

9.4.1. U.S.

9.4.2. Canada

9.5. North America Respiratory Monitoring Devices Market Attractiveness Analysis

9.5.1. By Product

9.5.2. By End User

9.5.3. By Country/Sub-region

10. Europe Respiratory Monitoring Devices Market Analysis and Forecast

10.1. Introduction

10.2. Europe Respiratory Monitoring Devices Market Value Forecast, by Product, 2017–2027

10.2.1. Pulse Oximeters

10.2.2. Capnographs

10.2.3. Spirometers

10.2.4. Polysomnographs (PSG)

10.2.5. Peak Flow Meters

10.2.6. Gas Analyzers

10.2.7. Others

10.3. Europe Respiratory Monitoring Devices Market Value Forecast, by End User, 2017–2027

10.3.1. Home care

10.3.2. Hospitals

10.3.3. Ambulatory Surgical Centers

10.3.4. Specialty Clinics

10.4. Europe Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017–2027

10.4.1. Germany

10.4.2. U.K.

10.4.3. France

10.4.4. Spain

10.4.5. Italy

10.4.6. Rest of Europe

10.5. Europe Respiratory Monitoring Devices Market Attractiveness Analysis

10.5.1. By Product

10.5.2. By End User

10.5.3. By Country/Sub-region

11. Asia Pacific Respiratory Monitoring Devices Market Analysis and Forecast

11.1. Introduction

11.2. Asia Pacific Respiratory Monitoring Devices Market Value Forecast, by Product, 2017–2027

11.2.1. Pulse Oximeters

11.2.2. Capnographs

11.2.3. Spirometers

11.2.4. Polysomnographs (PSG)

11.2.5. Peak Flow Meters

11.2.6. Gas Analyzers

11.2.7. Others

11.3. Asia Pacific Respiratory Monitoring Devices Market Value Forecast, by End User, 2017–2027

11.3.1. Home care

11.3.2. Hospitals

11.3.3. Ambulatory Surgical Centers

11.3.4. Specialty Clinics

11.4. Asia Pacific Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017–2027

11.4.1. Japan

11.4.2. China

11.4.3. India

11.4.4. Australia & New Zealand

11.4.5. Rest of Asia Pacific

11.5. Asia Pacific Respiratory Monitoring Devices Market Attractiveness Analysis

11.5.1. By Product

11.5.2. By End User

11.5.3. By Country/Sub-region

12. Latin America Respiratory Monitoring Devices Market Analysis and Forecast

12.1. Introduction

12.2. Latin America Respiratory Monitoring Devices Market Value Forecast, by Product, 2017–2027

12.2.1. Pulse Oximeters

12.2.2. Capnographs

12.2.3. Spirometers

12.2.4. Polysomnographs (PSG)

12.2.5. Peak Flow Meters

12.2.6. Gas Analyzers

12.2.7. Others

12.3. Latin America Respiratory Monitoring Devices Market Value Forecast, by End User, 2017–2027

12.3.1. Home care

12.3.2. Hospitals

12.3.3. Ambulatory Surgical Centers

12.3.4. Specialty Clinics

12.4. Latin America Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017–2027

12.4.1. Brazil

12.4.2. Mexico

12.4.3. Rest of Latin America

12.5. Latin America Respiratory Monitoring Devices Market Attractiveness Analysis

12.5.1. By Product

12.5.2. By End User

12.5.3. By Country/Sub-region

13. Middle East & Africa Respiratory Monitoring Devices Market Analysis and Forecast

13.1. Introduction

13.2. Middle East & Africa Respiratory Monitoring Devices Market Value Forecast, by Product, 2017–2027

13.2.1. Pulse Oximeters

13.2.2. Capnographs

13.2.3. Spirometers

13.2.4. Polysomnographs (PSG)

13.2.5. Peak Flow Meters

13.2.6. Gas Analyzers

13.2.7. Others

13.3. Middle East & Africa Respiratory Monitoring Devices Market Value Forecast, by End User, 2017–2027

13.3.1. Home care

13.3.2. Hospitals

13.3.3. Ambulatory Surgical Centers

13.3.4. Specialty Clinics

13.3.5. Hospitals

13.4. Middle East & Africa Respiratory Monitoring Devices Market Value Forecast, by Country/Sub-region, 2017–2027

13.4.1. GCC Countries

13.4.2. South Africa

13.4.3. Rest of Middle East & Africa

13.5. Middle East & Africa Respiratory Monitoring Devices Market Attractiveness Analysis

13.5.1. By Product

13.5.2. By End User

13.5.3. By Country/Sub-region

14. Competition Landscape

14.1. Global Respiratory Monitoring Devices Market Share Analysis, by Company (2018)

14.2. Company Profiles

14.2.1. Medtronic

14.2.1.1. Company Description

14.2.1.2. Business Overview

14.2.1.3. Financial Overview

14.2.1.4. Strategic Overview

14.2.1.5. SWOT Analysis

14.2.2. Philips Healthcare (Koninklijke Philips N.V.)

14.2.2.1. Company Description

14.2.2.2. Business Overview

14.2.2.3. Financial Overview

14.2.2.4. Strategic Overview

14.2.2.5. SWOT Analysis

14.2.3. Smiths Medical (part of Smiths Group plc)

14.2.3.1. Company Description

14.2.3.2. Business Overview

14.2.3.3. Financial Overview

14.2.3.4. Strategic Overview

14.2.3.5. SWOT Analysis

14.2.4. Dragerwerk AG & Co. KGaA

14.2.4.1. Company Description

14.2.4.2. Business Overview

14.2.4.3. Financial Overview

14.2.4.4. Strategic Overview

14.2.4.5. SWOT Analysis

14.2.5. GE Healthcare (part of General Electric Company)

14.2.5.1. Company Description

14.2.5.2. Business Overview

14.2.5.3. Financial Overview

14.2.5.4. Strategic Overview

14.2.5.5. SWOT Analysis

14.2.6. Welch Allyn, Inc. (Hill-Rom Holdings, Inc.)

14.2.6.1. Company Description

14.2.6.2. Business Overview

14.2.6.3. Financial Overview

14.2.6.4. Strategic Overview

14.2.6.5. SWOT Analysis

14.2.7. Masimo

14.2.7.1. Company Description

14.2.7.2. Business Overview

14.2.7.3. Financial Overview

14.2.7.4. Strategic Overview

14.2.7.5. SWOT Analysis

14.2.8. MGC Diagnostics Corporation

14.2.8.1. Company Description

14.2.8.2. Business Overview

14.2.8.3. SWOT Analysis

14.2.9. Vyaire Medical Inc. (Becton, Dickinson and Company and Apax Partners’ Joint Venture)

14.2.9.1. Company Description

14.2.9.2. Business Overview

14.2.9.3. Strategic Overview

14.2.9.4. SWOT Analysis

14.2.10. Nihon Kohden Corporation

14.2.10.1. Company Description

14.2.10.2. Business Overview

14.2.10.3. Financial Overview

14.2.10.4. Strategic Overview

14.2.10.5. SWOT Analysis

14.2.11. Novelda AS

14.2.11.1. Company Description

14.2.11.2. Business Overview

14.2.11.3. Strategic Overview

14.2.11.4. SWOT Analysis

List of Figures

Figure 01: Global Respiratory Monitoring Devices Size ($ Million) and Distribution by Geography, 2018 and 2027

Figure 02: Global Respiratory Monitoring Devices, by Region (2018)

Figure 03: Global Respiratory Monitoring Devices Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 04: Market Value Share by Product (%), 2018

Figure 05: Market Value Share by End User (%), 2018

Figure 06: Market Value Share by Geography (%), 2018

Figure 07: Global Respiratory Monitoring Devices Market Value Share, by Product, 2018 and 2027

Figure 08: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pulse Oximeters, 2017–2027

Figure 09: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Capnographs, 2017–2027

Figure 10: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Spirometers, 2017–2027

Figure 11: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Polysomnographs (PSG), 2017–2027

Figure 12: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Peak Flow Meters, 2017–2027

Figure 13: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Gas Analyzers, 2017–2027

Figure 14: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 15: Global Respiratory Monitoring Devices Market Attractiveness Analysis, by Product, 2019-2027

Figure 16: Global Respiratory Monitoring Devices Market Value Share, by End User, 2018 and 2027

Figure 17: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Home Care, 2017–2027

Figure 18: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027

Figure 19: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2017–2027

Figure 20: Global Respiratory Monitoring Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2017–2027

Figure 21: Global Respiratory Monitoring Devices Market Attractiveness Analysis, by End User, 2019-2027

Figure 22: Global Respiratory Monitoring Devices Market Value Share, by Region, 2018 and 2027

Figure 23: Global Respiratory Monitoring Devices Market Attractiveness Analysis, by Region, 2019-2027

Figure 24: North America Respiratory Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 25: North America Respiratory Monitoring Devices Market Share Analysis, by Product, 2018 and 2027

Figure 26: North America Respiratory Monitoring Devices Market Attractiveness Analysis, by Product, 2019–2027

Figure 27: North America Respiratory Monitoring Devices Market Share Analysis, by End User, 2018 and 2027

Figure 28: North America Respiratory Monitoring Devices Market Attractiveness Analysis, by End User, 2019–2027

Figure 29: North America Respiratory Monitoring Devices Market Value Share Analysis, by Country, 2018 and 2027

Figure 30: North America Respiratory Monitoring Devices Market Attractiveness Analysis, by Country, 2019–2027

Figure 31: Europe Respiratory Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 32: Europe Respiratory Monitoring Devices Market Share Analysis, by Product, 2018 and 2027

Figure 33: Europe Respiratory Monitoring Devices Market Attractiveness Analysis, by Product, 2019–2027

Figure 34: Europe Respiratory Monitoring Devices Market Share Analysis, by End User, 2018 and 2027

Figure 35: Europe Respiratory Monitoring Devices Market Attractiveness Analysis, by End User, 2019-2027

Figure 36: Europe Respiratory Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 37: Europe Respiratory Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 38: Asia Pacific Respiratory Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 39: Asia Pacific Respiratory Monitoring Devices Market Share Analysis, by Product, 2018 and 2027

Figure 40: Asia Pacific Respiratory Monitoring Devices Market Attractiveness Analysis, by Product, 2019–2027

Figure 41: Asia Pacific Respiratory Monitoring Devices Market Share Analysis, by End User, 2018 and 2027

Figure 42: Asia Pacific Respiratory Monitoring Devices Market Attractiveness Analysis, by End User, 2019–2027

Figure 43: Asia Pacific Respiratory Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 44: Asia Pacific Respiratory Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 45: Latin America Respiratory Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 46: Latin America Respiratory Monitoring Devices Market Share Analysis, by Product, 2018 and 2027

Figure 47: Latin America Respiratory Monitoring Devices Market Attractiveness Analysis, by Product, 2019–2027

Figure 48: Latin America Respiratory Monitoring Devices Market Share Analysis, by End User, 2018 and 2027

Figure 49: Latin America Respiratory Monitoring Devices Market Attractiveness Analysis, by End User, 2019–2027

Figure 50: Latin America Respiratory Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 51: Latin America Respiratory Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 52: Middle East & Africa Respiratory Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 53: Middle East & Africa Respiratory Monitoring Devices Market Share Analysis, by Product, 2018 and 2027

Figure 54: Middle East & Africa Respiratory Monitoring Devices Market Attractiveness Analysis, by Product

Figure 55: Middle East & Africa Respiratory Monitoring Devices Market Share Analysis, by End User, 2018 and 2027

Figure 56: Middle East & Africa Respiratory Monitoring Devices Market Attractiveness Analysis, by End User, 2019-2027

Figure 57: Middle East & Africa Respiratory Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 58: Middle East & Africa Respiratory Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 59: Global Respiratory Monitoring Devices Market Share Analysis, by Company (2017)

Figure 60: Medtronic Respiratory, Gastrointestinal, & Renal Division Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2018

Figure 61: Medtronic Breakdown of Net Sales (%) of Minimally Invasive Therapies Group, by Region, 2018

Figure 62: Medtronic Minimally Invasive Therapies Group Segment Breakdown of Net Sales (%), by Division, 2018

Figure 63: Medtronic R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 64: Philips Group Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 65: Philips Group Breakdown of Net Sales (%), by Region, 2018

Figure 66: Philips Group R&D Expenditure (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 67: Philips Group Breakdown of Net Sales (%), by Business Segment, 2018

Figure 68: Smiths Medical Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2019

Figure 69: Smiths Group plc Breakdown of Net Sales (%), by Region, 2019

Figure 70: Smiths Group plc R&D Expenditure (US$ Mn) and Y-o-Y Growth (%), 2017–2019

Figure 71: Smiths Medical Breakdown of Net Sales (%), by Sector, 2019

Figure 72: Dragerwerk AG & Co. KGaA (Medical Group) Revenue (US$ Mn), 2016–2018

Figure 73: Dragerwerk AG & Co. KGaA Breakdown of Net Sales (%), by Region, 2018

Figure 74: Dragerwerk AG & Co. KGaA R&D Expenditure (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 75: Dragerwerk AG & Co. KGaA Breakdown of Net Sales (%), by Business Segment, 2018

Figure 76: GE Healthcare Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 77: GE Healthcare Breakdown of Healthcare Business Segment Net Sales (%), by Region, 2018

Figure 78: GE Healthcare R&D Expenditure (US$ Mn) and Y-o-Y Growth (%),

Figure 79: GE Healthcare Breakdown of Net Sales (%), by Healthcare Sub-Segment, 2018

Figure 80: Hill-Rom Holdings, Inc. Revenue, (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 81: Hill-Rom Holdings, Inc., Breakdown of Net Sales (%), by Geography, 2018

Figure 82: Hill-Rom Holdings, Inc., Breakdown of Net Sales (%), by Business Segment, 2018

Figure 83: Hill-Rom Holdings, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 84: Masimo Revenue, (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 85: Masimo Breakdown of Net Sales (%), by Geography, 2018

Figure 86: Masimo R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 87: Nihon Kohden Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018

Figure 88: Nihon Kohden Corporation Breakdown of Net Sales (%), by Product, 2018

Figure 89: Nihon Kohden Corporation R&D Expenditure (US$ Mn) and Y-o-Y Growth (%),

Figure 90: Nihon Kohden Corporation Breakdown of Healthcare Business Segment Net Sales (%), by Region, 2018